ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Two Studies Advance The Treatment Of Early-Stage And Later Breast Cancer

June 27, 2008

NCI Names Brawly Director of Office of Special Populations

June 21, 1996

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Network Should Collect Some Environmental Information: Collins

August 9, 1996

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds

December 28, 2007